Navigation Links
CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
Date:10/17/2008

rrently prescribed antidepressant drugs."

CeNeRx has worldwide rights to develop and commercialize Tyrima. This compound, which could be the first RIMA antidepressant available in the U.S. market, has patent protection beyond 2027.

About CeNeRx BioPharma

CeNeRx is a privately held clinical stage biopharmaceutical company developing and commercializing innovative treatments for diseases of the central nervous system. CeNeRx's most advanced compound, a reversible inhibitor of monoamine oxidase, or RIMA, has entered Phase II development for the treatment of major depressive disorder. RIMAs may have efficacy advantages over current agents for depression and are expected to have a good safety profile. The company is also developing its pipeline of selective cannabinoid compounds that have recently completed successful preclinical proof-of-concept studies for the treatment of pain, glaucoma and spasticity. More information about CeNeRx BioPharma can be found at http://www.cenerx.com.

Contact:

GendeLLindheim BioCom Partners

Barbara Lindheim

212 918 4650


'/>"/>
SOURCE CeNeRx BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
2. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
3. InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
4. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
5. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
6. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
7. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
8. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
9. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
10. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
11. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...0 Reportlinker.com announces that ...atalogue. ,, Medical Adhesives and Sealants - ...r.com/p0164242/Medical-Adhesives-and-Sealants---A-...m_medium=pr&utm_campaign=prnewswire ,, Th... preeminence in medical devices and equipments. Cu...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:... and Chief Executive Officer, and Greg Browne, Chi...ual Piper Jaffray Health Care Conference in New Yo... The conference session and webcast will be audio...er Jaffray will host a webcast of the presentation...
(Date:11/20/2009)... 20 Smith & Nephew (... announce the signing of a technology development ...nse that may lead to the creation of a fracture fi...ent of the limbs of soldiers who sustain battlefie... Research Projects Agency (DARPA), the central res...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 476 Children Dead From Swine Flu 3A CDC 59232 176 Children Dead From Swine Flu 3A CDC 59232 276 Children Dead From Swine Flu 3A CDC 59232 3American Heart Association Guidelines Save Lives 59228 1American Heart Association Guidelines Save Lives 59228 2Amended Chairmans Mark Sets Stage for 26quot 3BHitting Bulls eye in Health Reform 26quot 3B 59224 1Amended Chairmans Mark Sets Stage for 26quot 3BHitting Bulls eye in Health Reform 26quot 3B 59224 2
...ial for Cervical Dysplasia to Begin Mid-2008 -, S...oration (TSX: NVN) today announced the completion ...ourth and final cohort of patients in its,Phase 1 ...idate, in women,with cervical intraepithelial neop...y review demonstrated that HspE7 was safe and well...
...O, April 24 Elekta, a global leader,in minimally ... of,stereotactic solutions at the 76th Annual Meet...rgeons, (AANS), April 26 - May 1 in Chicago,Illino...exion(TM) and,Elekta Axesse(TM), two stereotactic ...ities for the most challenging cases., Now in cli...
Other Medicine Technology:Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial 5Elekta's New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time 2
(Date:11/20/2009)..., Nov. 20 SIRIUS XM Rad...broadcast Doctor Radio Reports: What Every Wome...cial hosted by veteran journalist Perri Peltz. ,...080819/NYTU044LOGO ) ,, Doctor Radio Reports... will air November 21 live at 10:00 am ET on Doc...
(Date:11/20/2009)...November 20, 2009Emergency medical service (EMS) p...350,000 cardiac arrests each year. Only 5 to 10 p...rvive. Better quality cardiopulmonary resuscitati... be associated with better patient outcome. The R...est clinical research network to study prehospital...
(Date:11/20/2009)...e severe cases than with seasonal flu , ...searchers are reporting that children with asthma ...u than seasonal flu. , "Asthma has been identif...h pandemic H1N1 influenza, present in 21 percent t...on Allen and fellow researchers from the Hospital ...
(Date:11/20/2009)...Mo., Nov. 20 Missouri state employ...gions will now have the option to choose Mercy Hea...etween Missouri Consolidated Health Care Plan (MCH...d South Central Missouri regions include the follo...de, Dallas, Douglas, Greene, Hickory, Howell, Jasp...
(Date:11/20/2009)...ov. 20 Today, iconic denim brand ...e the launch of a capsule gift giving collection o...day season. This collection is inspired by and de...,s Thanks and Giving® Program, a holiday fu...onsumers to "give thanks for the healthy kids in y...
Breaking Medicine News(10 mins):Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3
...mmitment to industry best practices, meets new ...INNEAPOLIS, Aug. 21 National health care consulti...the development of a,comprehensive accreditation p...ion Commission (URAC)., The URAC assistance progr...
... 2008 Inc. 5,000 list, experiences three-year ...RTLAND, Ore., Aug. 21 Inc. recently unveiled Vigi... fastest-growing private,companies in the United S...igilan delivers operational management software to...
...The Pancreatic Cancer,Action Network ( http://www....ing hope in a comprehensive way through research, ...r a cure, is saddened by the loss of NFL,Hall of F...Fleshman, President,and CEO. "I know personally th...
...youngsters, so sex ed should be added to lineup, s...y News) -- One reason why abstinence-only programs...because abstinence can mean different things to te...titudes and intentions about being abstinent, the ...
...w names and fresh website highlight stronger focus...ftware , Vancouver, BC (P... provider of healthcare education administration s...tion products., , ,CompleteM.E. and FacultyTrack r...
...Association of,International Automobile Manufactur...esearch initiative conducted by the Children,s Hos...port for the largest source of,data on children in...mproved federal motor vehicle safety standards,pub...
Other Medicine News:Health News:Halleland Health Consulting Establishes URAC Accreditation Program 2Health News:Vigilan Recognized as One of the Fastest-Growing Private Companies in the U.S. 2Health News:The Pancreatic Cancer Action Network is Saddened by the Death of NFL Hall of Fame Member Gene Upshaw 2Health News:Abstinence-Only Programs Fall Short of Teens' Needs 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:AIAM Sponsors Leading Child Safety Research Initiative 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: